OTTAWA, March 7, 2013 /CNW/ - Following the death of a child enrolled in
a clinical trial for the drug Sensipar in the United States, Health
Canada is reminding healthcare professionals and consumers that
Sensipar is not approved for use in patients under 18 years of age.
Sensipar...
Trending Articles
More Pages to Explore .....